233 related articles for article (PubMed ID: 31441123)
1. Characterization of LDLR rs5925 and PCSK9 rs505151 genetic variants frequencies in healthy subjects from northern Chile: Influence on plasma lipid levels.
Rojas C; Ramírez H; Salazar LA; Kalergis AM; Gálvez AS; Escobar-Vera J
J Clin Lab Anal; 2019 Nov; 33(9):e23001. PubMed ID: 31441123
[TBL] [Abstract][Full Text] [Related]
2. What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis.
Qiu C; Zeng P; Li X; Zhang Z; Pan B; Peng ZYF; Li Y; Ma Y; Leng Y; Chen R
Lipids Health Dis; 2017 Jun; 16(1):111. PubMed ID: 28606094
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome.
Xavier LB; Sóter MO; Sales MF; Oliveira DK; Reis HJ; Candido AL; Reis FM; Silva IO; Gomes KB; Ferreira CN
Gene; 2018 Feb; 644():129-136. PubMed ID: 29109005
[TBL] [Abstract][Full Text] [Related]
4. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
[TBL] [Abstract][Full Text] [Related]
5. Correlations of PCSK9 and LDLR Gene Polymorphisms and Serum PCSK9 Levels With Atherosclerosis and Lipid Metabolism in Patients on Maintenance Hemodialysis.
Cui J; Qiu Y; Kang N; Lu J; Zheng L
J Clin Pharmacol; 2023 Dec; 63(12):1430-1437. PubMed ID: 37563753
[TBL] [Abstract][Full Text] [Related]
6. Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.
Hori M; Ohta N; Takahashi A; Masuda H; Isoda R; Yamamoto S; Son C; Ogura M; Hosoda K; Miyamoto Y; Harada-Shiba M
Atherosclerosis; 2019 Oct; 289():101-108. PubMed ID: 31491741
[TBL] [Abstract][Full Text] [Related]
7.
Mohamed SH; Hassaan MMM; Ibrahim BA; Sabbah NA
Genet Test Mol Biomarkers; 2021 Sep; 25(9):615-623. PubMed ID: 34550777
[No Abstract] [Full Text] [Related]
8. Interactions of several genetic polymorphisms and alcohol consumption on blood pressure levels.
Yin RX; Aung LH; Long XJ; Yan TT; Cao XL; Huang F; Wu JZ; Yang DZ; Lin WX; Pan SL
Biofactors; 2015; 41(5):339-51. PubMed ID: 26354227
[TBL] [Abstract][Full Text] [Related]
9. Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels.
Aung LH; Yin RX; Wu DF; Cao XL; Hu XJ; Miao L
Int J Med Sci; 2013; 10(2):124-32. PubMed ID: 23329883
[TBL] [Abstract][Full Text] [Related]
10. Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations.
Hayat M; Kerr R; Bentley AR; Rotimi CN; Raal FJ; Ramsay M
PLoS One; 2020; 15(2):e0229098. PubMed ID: 32084179
[TBL] [Abstract][Full Text] [Related]
11. The proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Aung LH; Yin RX; Miao L; Hu XJ; Yan TT; Cao XL; Wu DF; Li Q; Pan SL; Wu JZ
Lipids Health Dis; 2011 Jan; 10():5. PubMed ID: 21232153
[TBL] [Abstract][Full Text] [Related]
12. Patients With
Doi T; Hori M; Harada-Shiba M; Kataoka Y; Onozuka D; Nishimura K; Nishikawa R; Tsuda K; Ogura M; Son C; Miyamoto Y; Noguchi T; Shimokawa H; Yasuda S
J Am Heart Assoc; 2021 Feb; 10(4):e018263. PubMed ID: 33533259
[TBL] [Abstract][Full Text] [Related]
13. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.
Jang HD; Lee SE; Yang J; Lee HC; Shin D; Lee H; Lee J; Jin S; Kim S; Lee SJ; You J; Park HW; Nam KY; Lee SH; Park SW; Kim JS; Kim SY; Kwon YW; Kwak SH; Yang HM; Kim HS
Eur Heart J; 2020 Jan; 41(2):239-252. PubMed ID: 31419281
[TBL] [Abstract][Full Text] [Related]
14. The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis.
Cai G; Zhang B; Shi G; Weng W; Ma C; Song Y; Zhang J
Lipids Health Dis; 2015 Nov; 14():149. PubMed ID: 26576960
[TBL] [Abstract][Full Text] [Related]
15. Single Nucleotide Polymorphisms in
Gálvez AS; Ramírez H; Placencia P; Rojas C; Urzúa X; Kalergis AM; Salazar LA; Escobar-Vera J
Front Genet; 2021; 12():640956. PubMed ID: 34616421
[TBL] [Abstract][Full Text] [Related]
16. Association between Apo B, LDL-R and PCSK9 gene polymorphisms with coronary artery diseases in Egyptians.
Mahsoub N; Almenshawy A; Taki Eldin AM; Abdel Hay NM; Youssef AR; El-Farahaty RM; El-Sayed K; Osman AM; Elhennawy ES
Mol Biol Rep; 2024 Jun; 51(1):752. PubMed ID: 38874786
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways.
Cameron J; Bogsrud MP; Tveten K; Strøm TB; Holven K; Berge KE; Leren TP
Transl Res; 2012 Aug; 160(2):125-30. PubMed ID: 22683370
[TBL] [Abstract][Full Text] [Related]
18. The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia.
Lipids Health Dis; ; . PubMed ID: 32252761
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
